{
    "eid": "2-s2.0-85052940418",
    "title": "Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis",
    "cover-date": "2018-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Otorhinolaryngology",
            "@code": "2733",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "allergic rhinitis",
        "antihistamines",
        "corticosteroids",
        "histamine antagonist",
        "steroids"
    ],
    "authors": [
        "Kachorn Seresirikachorn",
        "Wirach Chitsuthipakorn",
        "Dichapong Kanjanawasee",
        "Likhit Khattiyawittayakun",
        "Kornkiat Snidvongs"
    ],
    "citedby-count": 18,
    "ref-count": 45,
    "ref-list": [
        "Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)",
        "Clinical practice guideline: allergic rhinitis",
        "Update on intranasal medications in rhinosinusitis",
        "Mechanisms of glucocorticoid action in chronic rhinosinusitis",
        "Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits",
        "Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study",
        "Antihistamines for treating rhinosinusitis: systematic review and meta-analysis of randomised controlled studies",
        "BSACI guidelines for the management of allergic and non-allergic rhinitis",
        "Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis",
        "MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety",
        "Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device",
        "A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis",
        "Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis",
        "Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis",
        "Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis",
        "Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination",
        "Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis",
        "Efficacy and safety of ketotifen eye drops as adjunctive therapy to mometasone nasal spray in subjects with seasonal allergic rhinoconjunctivitis",
        "Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis",
        "Comparison of intranasal ciclesonide, oral levocetirizine, and combination treatment for allergic rhinitis",
        "A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis",
        "Budesonide and terfenadine, separately and in combination, in the treatment of hay fever",
        "The effect of combined medical treatment on quality of life in persistent allergic rhinitis",
        "MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children",
        "Mode of action of intranasal corticosteroids",
        "Anti-inflammatory properties of desloratadine",
        "Histamine and H1-antihistamines: celebrating a century of progress",
        "Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review",
        "Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis",
        "Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis",
        "Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy",
        "The efficacy of intranasal antihistamines in the treatment of allergic rhinitis",
        "Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine",
        "An assessment of the onset and duration of action of olopatadine nasal spray",
        "Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine",
        "Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial",
        "A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis",
        "Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis",
        "A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis",
        "International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis",
        "Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update",
        "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines\u20142016 revision",
        "Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Ratchasima",
            "@id": "60013120",
            "affilname": "Maharaj Nakhon Ratchasima Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013120",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Sawan",
            "@id": "114159116",
            "affilname": "Sawan Pracharak Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114159116",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}